Literature DB >> 22465089

Over-nutrition and metabolic cardiomyopathy.

Chirag H Mandavia1, Lakshmi Pulakat, Vincent DeMarco, James R Sowers.   

Abstract

Cardiovascular disease, which accounts for the highest morbidity and mortality in the United States, has several major risk factors, including aging and diabetes. Overweight and obesity, especially abdominal obesity, have been increasingly implicated as independent risk factors in the development of cardiovascular disease. Metabolic and/or diabetic cardiomyopathy has been especially associated with excess body weight caused by chronic over-nutrition and high-fat feeding. In the initial stages, obesity is now understood to cause significant dysregulation of cardiac fatty acid and glucose metabolism. These abnormalities are due, in part, to increased oxidative stress, which in turn can cause deleterious effects on intracellular signaling pathways that control cellular growth and proliferation. This increase in oxidative stress is coupled with reduced anti-oxidant species and dysregulation of metabolic signaling pathways. The cardiomyopathy seen with obesity is associated with increased interstitial fibrosis and diastolic dysfunction. Over time, evolving abnormalities include hypertrophy and systolic dysfunction, eventually leading to heart failure.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465089      PMCID: PMC3393834          DOI: 10.1016/j.metabol.2012.02.013

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  44 in total

Review 1.  Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Sivakumar Ardhanari; Anand Chockalingam; Rukhsana Gul; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

2.  ER stress and its functional link to mitochondria: role in cell survival and death.

Authors:  Jyoti D Malhotra; Randal J Kaufman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

Review 3.  High fat diet induced diabetic cardiomyopathy.

Authors:  Ellen Dirkx; Robert W Schwenk; Jan F C Glatz; Joost J F P Luiken; Guillaume J J M van Eys
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-05-14       Impact factor: 4.006

4.  Down-regulated energy metabolism genes associated with mitochondria oxidative phosphorylation and fatty acid metabolism in viral cardiomyopathy mouse heart.

Authors:  Jing Xu; Hong-gang Nie; Xiao-dong Zhang; Ye Tian; Bo Yu
Journal:  Mol Biol Rep       Date:  2010-12-03       Impact factor: 2.316

5.  Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.

Authors:  Sreeja Purushothaman; Mb Mohamed Sathik; R Renuka Nair
Journal:  J Cardiovasc Pharmacol       Date:  2011-09       Impact factor: 3.105

Review 6.  Lipotoxicity in type 2 diabetic cardiomyopathy.

Authors:  Tineke van de Weijer; Vera B Schrauwen-Hinderling; Patrick Schrauwen
Journal:  Cardiovasc Res       Date:  2011-07-29       Impact factor: 10.787

7.  Indices of obesity and cardiometabolic risk.

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2011-10-24       Impact factor: 10.190

8.  Rac1 is required for cardiomyocyte apoptosis during hyperglycemia.

Authors:  E Shen; Yanwen Li; Ying Li; Limei Shan; Huaqing Zhu; Qingping Feng; J Malcolm O Arnold; Tianqing Peng
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

Review 9.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

10.  Cardiomyocyte-Restricted Deletion of PPARβ/δ in PPARα-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation.

Authors:  Jian Liu; Peiyong Wang; Lan He; Yuquan Li; Jinwen Luo; Lihong Cheng; Qianhong Qin; Lawrence A Brako; Woo-Kuen Lo; William Lewis; Qinglin Yang
Journal:  PPAR Res       Date:  2011-09-05       Impact factor: 4.964

View more
  26 in total

Review 1.  Nuclear tropomyosin and troponin in striated muscle: new roles in a new locale?

Authors:  P Bryant Chase; Mark P Szczypinski; Elliott P Soto
Journal:  J Muscle Res Cell Motil       Date:  2013-08-02       Impact factor: 2.698

Review 2.  Autophagy: a housekeeper in cardiorenal metabolic health and disease.

Authors:  Guanghong Jia; James R Sowers
Journal:  Biochim Biophys Acta       Date:  2014-06-28

3.  Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications.

Authors:  Sammy Elmariah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-07

Review 4.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

Review 5.  Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Authors:  Chirag H Mandavia; Annayya R Aroor; Vincent G Demarco; James R Sowers
Journal:  Life Sci       Date:  2012-11-09       Impact factor: 5.037

Review 6.  Insulin resistance and heart failure: molecular mechanisms.

Authors:  Annayya R Aroor; Chirag H Mandavia; James R Sowers
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

7.  Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.

Authors:  Adam T Whaley-Connell; Javad Habibi; Annayya Aroor; Lixin Ma; Melvin R Hayden; Carlos M Ferrario; Vincent G Demarco; James R Sowers
Journal:  Metabolism       Date:  2013-09-24       Impact factor: 8.694

Review 8.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

9.  Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.

Authors:  Brian Bostick; Javad Habibi; Lixin Ma; Annayya Aroor; Nathan Rehmer; Melvin R Hayden; James R Sowers
Journal:  Metabolism       Date:  2014-04-12       Impact factor: 8.694

Review 10.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.

Authors:  Guanghong Jia; Vincent G DeMarco; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2015-12-18       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.